Companies: 10,795·Total market cap: $144.5T
INNOCAN PHARMA Corp

INNOCAN PHARMA Corp

INNPFOTCHealthcare● Active
$2.40
$-0.05(-2.04%)
Market Cap$10797048
P/E Ratio—
52W High$14.26
52W Low$2.354
PE RatioMarket CapForecast

INNOCAN PHARMA Corp (INNPF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

innpf · pe ratio · data through Jun 9, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
INNOCAN PHARMA Corp
INNOCAN PHARMA CorpYou
INNPF
$11MN/A——
Biostage, Inc.
Biostage, Inc.
BSTG
$58MN/A—-$0.42
Ecofibre Limited
Ecofibre Limited
EOFBY
$74MN/A—-$0.12
Goodness Growth Holdings, Inc.
Goodness Growth Holdings, Inc.
GDNSF
$61MN/A—-$0.00
Healthcare Integrated Technologies, Inc.
Healthcare Integrated Technologies, Inc.
HITC
$53MN/A—-$0.04
Herantis Pharma Oyj
Herantis Pharma Oyj
HRPMF
$59MN/A—-$0.24
MCI Onehealth Technologies Inc.
MCI Onehealth Technologies Inc.
MCIOF
$54MN/A——

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for INNOCAN PHARMA Corp (INNPF) measures how much investors pay for each dollar of the company's trailing earnings. INNPF's current PE ratio of N/A is calculated by dividing its stock price of $2.40 by its TTM earnings per share of —.

PE Ratio = Stock Price ÷ EPS (TTM)
= $2.40 ÷ — = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

INNPF pe ratio · 6 questions

INNPF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.40 and TTM EPS of —. Data sourced from Financial Modeling Prep via INNPF's SEC 10-K and 10-Q filings.

INNPF PE ratioWhat is INNPF PE ratioCurrent PE ratio of INNPFINNPF PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · INNOCAN PHARMA Corp SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09